CCR7 Recombinant Rabbit Monoclonal Antibody [SR36-04]
Usd: 205 Special Discount
Specification
Safety datasheet
Overview
Product Name
CCR7 Recombinant Rabbit Monoclonal Antibody [SR36-04]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within Human CCR7 aa 13-62 / 378.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, IP
Molecular Weight
Predicted band size: 43 kDa
Positive Control
HDLM-2 cell lysate, Jurkat cell lysate, Daudi cell lysate, MCF7 cell lysate, mouse spleen tissue lysate, mouse pancreas tissue lysate, rat spleen tissue lysate, Raji cell lysate, EL4 cell lysate, RAW264.7 cell lysate, C6 cell lysate, Daudi, RAW264.7, C6.
Conjugation
unconjugated
Clone Number
SR36-04
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:2,000-1:5,000
-
IF-Cell
-
1:200-1:500
-
IP
-
1-2μg/sample
Target
Function
C-C chemokine receptor type 7 is a protein that in humans is encoded by the CCR7 gene. Two ligands have been identified for this receptor: the chemokines (C-C motif) ligand 19 (CCL19/ELC) and (C-C motif) ligand 21 (CCL21). CCR7 has also recently been designated CD197 (cluster of differentiation 197). The protein encoded by this gene is a member of the G protein-coupled receptor family. This receptor was identified as a gene induced by the Epstein-Barr virus (EBV), and is thought to be a mediator of EBV effects on B lymphocytes. This receptor is expressed in various lymphoid tissues and activates B and T lymphocytes. CCR7 has been shown to stimulate dendritic cell maturation. CCR7 is also involved in homing of T cells to various secondary lymphoid organs such as lymph nodes and the spleen as well as trafficking of T cells within the spleen. Activation of Dendritic cells in peripheral tissues induces CCR7 expression on the cell's surface, which recognize CCL19 and CCL21 produced in the Lymph node and increases dendritic cell expression of co-stimulation molecules (B7), and MHC class I or MHC class II.
Background References
1. Pang MF et al. TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis. Oncogene N/A:N/A (2015).
2. Guo J et al. Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma. Oncol Lett 5:1572-1578 (2013).
Sequence Similarity
Belongs to the G-protein coupled receptor 1 family.
Tissue Specificity
Expressed in various lymphoid tissues and activated B- and T-lymphocytes, strongly up-regulated in B-cells infected with Epstein-Barr virus and T-cells infected with herpesvirus 6 or 7.
Subcellular Location
Cell membrane.
Synonyms
BLR 2 antibody
BLR2 antibody
C C chemokine receptor type 7 antibody
C C CKR 7 antibody
C-C chemokine receptor type 7 antibody
C-C CKR-7 antibody
CC chemokine receptor 7 antibody
CC chemokine receptor type 7 antibody
CC CKR 7 antibody
CC-CKR-7 antibody
ExpandBLR 2 antibody
BLR2 antibody
C C chemokine receptor type 7 antibody
C C CKR 7 antibody
C-C chemokine receptor type 7 antibody
C-C CKR-7 antibody
CC chemokine receptor 7 antibody
CC chemokine receptor type 7 antibody
CC CKR 7 antibody
CC-CKR-7 antibody
CCCKR7 antibody
CCR 7 antibody
CCR-7 antibody
Ccr7 antibody
CCR7_HUMAN antibody
CD 197 antibody
CD197 antibody
CD197 antigen antibody
CDw197 antibody
Chemokine (C C motif) receptor 7 antibody
Chemokine (C C) receptor 7 antibody
Chemokine C C motif receptor 7 antibody
Chemokine C C receptor 7 antibody
Chemokine receptor 7 antibody
Chemokine receptor 7-like protein antibody
CMKBR7 antibody
EBI 1 antibody
EBI1 antibody
Ebi1h antibody
EBV Induced G Protein Coupled Receptor 1 antibody
EBV-induced G-protein coupled receptor 1 antibody
Epstein Barr virus induced G protein coupled receptor antibody
Epstein Barr virus induced gene 1 antibody
Epstein-Barr virus-induced G-protein coupled receptor 1 antibody
EVI 1 antibody
EVI1 antibody
Lymphocyte Specific G Protein Coupled Peptide Receptor antibody
MGC108519 antibody
MIP 3 beta receptor antibody
MIP-3 beta receptor antibody
MIP3 Beta Receptor antibody
CollapseImages
-
☑ Knockdown (KD)
All lanes: Western blot analysis of CCR7 with anti-CCR7 antibody (ET1602-22) at 1:5,000 dilution.
Lane 1/2: Wild-type Hela whole cell lysate (10 µg).
Lane 3/4: CCR7 fragment 1 knockdown Hela whole cell lysate (10 µg).
Lane 5/6: CCR7 fragment 2 knockdown Hela whole cell lysate (10 µg).
ET1602-22 was shown to specifically react with CCR7 in wild-type Hela cells. Weakened was observed when CCR7 knockdown sample was tested. Wild-type and CCR7 knockdown samples were subjected to SDS-PAGE. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM in TBST for 1 hour at room temperature. The primary antibody (ET1602-22, 1/500) and Loading control antibody (Rabbit anti-GAPDH, ET1601-4, 1/10,000) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG-HRP Secondary Antibody (HA1001) at 1:200,000 dilution was used for 1 hour at room temperature. -
☑ Relative expression (RE)
Western blot analysis of CCR7 on different lysates with Rabbit anti-CCR7 antibody (ET1602-22) at 1/5,000 dilution.
Lane 1: HDLM-2 cell lysate
Lane 2: Jurkat cell lysate
Lane 3: Daudi cell lysate
Lane 4: MCF7 cell lysate
Lane 5: Mouse spleen tissue lysate
Lane 6: Mouse pancreas tissue lysate (low expression)
Lane 7: Rat spleen tissue lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 43 kDa
Observed band size: 43 kDa
Exposure time: 24 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1602-22) at 1/5,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:50,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of CCR7 on different lysates with Rabbit anti-CCR7 antibody (ET1602-22) at 1/2,000 dilution.
Lane 1: Raji cell lysate
Lane 2: Daudi cell lysate
Lane 3: EL4 cell lysate
Lane 4: RAW264.7 cell lysate
Lane 5: C6 cell lysate
Lane 6: Rat spleen tissue lysate
Lysates/proteins at 15 µg/Lane.
Predicted band size: 43 kDa
Observed band size: 43 kDa
Exposure time: 10 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1602-22) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of Daudi cells labeling CCR7 with Rabbit anti-CCR7 antibody (ET1602-22) at 1/250 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-CCR7 antibody (ET1602-22) at 1/250 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of RAW264.7 cells labeling CCR7 with Rabbit anti-CCR7 antibody (ET1602-22) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-CCR7 antibody (ET1602-22) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of C6 cells labeling CCR7 with Rabbit anti-CCR7 antibody (ET1602-22) at 1/200 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-CCR7 antibody (ET1602-22) at 1/200 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
CCR7 was immunoprecipitated from 0.2 mg Daudi cell lysate with ET1602-22 at 2 µg/10 µl beads. Western blot was performed from the immunoprecipitate using ET1602-22 at 1/2,000 dilution. Anti-Rabbit IgG for IP Nano-secondary antibody (NBI01H) at 1/5,000 dilution was used for 1 hour at room temperature.
Lane 1: Daudi cell lysate (input)
Lane 2: ET1602-22 IP in Daudi cell lysate
Lane 3: Rabbit IgG instead of ET1602-22 in Daudi cell lysate
Blocking/Dilution buffer: 5% NFDM/TBST
Exposure time: 8 seconds; ECL: K1802
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
An Engineered Extracellular Vesicle With Enhanced Tumor and Lymph Nodes Targeting as siRNA Delivery System for Robust Tumor Immunotherapy
Journal: Medicine And Communication
DOI: 10.1002/mco2.70673
IF: 10.7
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
Scab-Inspired Thermoresponsive Hydrogel Dressing for Accelerated Healing of Infected Wounds
Journal: ACS Applied Materials & Interfaces
DOI: 10.1021/acsami.5c21571
IF: 8.2
Application: WB
Reactivity: Mouse
Publish date: 2026 Jan
-
Sensory neuron TRPV1-mediated macrophage polarization and immune response regulate dental implant osseointegration
Journal: Tissue & Cell
DOI: 10.1016/j.tice.2025.103243
IF: 2.5
Application: IF-cell
Reactivity: Mouse
Publish date: 2025 Nov
-
Facile Formulation of a Resveratrol-Mediated Multibond Network Hydrogel with Efficient Sustainable Antibacterial, Reactive Oxygen Species Scavenging, Pro-Angiogenesis, and Immunomodulation Activities for Accelerating Infected Wound Healing
Journal: ACS Applied Materials & Interfaces
DOI:
IF: 8.3
Application: IF-cell
Reactivity: Mouse
Publish date: 2025 Jan
-
Optineurin restrains CCR7 degradation to guide type II collagen-stimulated dendritic cell migration in rheumatoid arthritis
Journal: Acta Pharmaceutica Sinica B
DOI: 10.1016/j.apsb.2025.02.004
IF: 14.7
Application: WB,Co-IP
Reactivity: Mouse
Publish date: 2025 Feb
-
Chemokine receptor 7 contributes to T-and B-cell filtering in ageing bladder, cystitis and bladder cancer
Journal: Immunity & Ageing
DOI:
IF: 7.9
Application: IHC-P,WB
Reactivity: Human,Mouse
Publish date: 2024 May
-
Initial IL-10 production dominates the therapy of mesenchymal stem cell scaffold in spinal cord injury
Journal: Theranostics
DOI:
IF: 12.4
Application: WB
Reactivity: Rat
Publish date: 2024 Jan
-
Characterizing the tumor microenvironment at the single-cell level reveals a novel immune evasion mechanism in osteosarcoma
Journal: Bone Research
DOI:
IF: 13.362
Application: IF-tissue
Reactivity: Human
Publish date: 2023 Jan
-
Electrospun naringin-loaded microsphere/sucrose acetate isobutyrate system promotes macrophage polarization toward M2 and facilitates osteoporotic bone defect repair
Journal: Regenerative Biomaterials
DOI:
IF: 5.763
Application: IF-cell
Reactivity: Mouse
Publish date: 2023 Feb
-
FSH promotes immature porcine Sertoli cell proliferation by activating the CCR7/Ras-ERK signaling axis
Journal: Reproduction
DOI:
IF: 3.8
Application: WB
Reactivity: Pig
Publish date: 2023 Apr
Products with the same target and pathway
HRP Conjugated CCR7 Recombinant Rabbit Monoclonal Antibody [SR36-04]
Application: WB
Reactivity: Human,Mouse,Rat
Conjugate: HRP
CCR7 Recombinant Rabbit Monoclonal Antibody [SR36-04] - BSA and Azide free
Application: WB,IF-Cell,IP
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
iFluor™ 488 Conjugated CCR7 Recombinant Rabbit Monoclonal Antibody [SR36-04]
Application: IF-Cell,IF-Tissue
Reactivity: Human,Mouse,Rat
Conjugate: iFluor™ 488